Loading...
Market
Will CDO-7N-1 antibody receive Emergency Use Authorization (EUA) by December 31, 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA official announcements and website
Story
Texas Biomed Discovers Antibody CDO-7N-1 Neutralizing All COVID-19 Variants
Sep 10, 2024, 12:27 PM
Researchers at Texas Biomed have discovered an antibody, CDO-7N-1, that can neutralize all known variants of SARS-CoV-2, the virus responsible for COVID-19. This antibody induces immunity to all major SARS-CoV-2 proteins and is highly effective against all major variants to date. Additionally, the antibody has shown effectiveness against distantly related SARS-like coronaviruses that infect other animals. This breakthrough could have significant implications for the treatment and prevention of COVID-19 and related viral infections.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
